Justice Department discusses Importer of Controlled Substances Application: Royal Emerald Pharmaceuticals Research and Development on April 28

Justice Department discusses Importer of Controlled Substances Application: Royal Emerald Pharmaceuticals Research and Development on April 28

The US Justice Department published a two page notice on April 28, according to the U.S. Government Publishing Office.

The notice is focused on Importer of Controlled Substances Application: Royal Emerald Pharmaceuticals Research and Development.

The Department is one of the oldest in the US, focused primarily on law enforcement and the federal prison system. Downsizing the Federal Government, a project aimed at lowering taxes and boosting federal efficiency, detailed wasteful expenses such as $16 muffins at conferences and board meetings.

Notices are required documents detailing rules and regulations being proposed by each federal department. This allows the public to see what issues legislators and federal departments are focusing on.

Any person or organization can comment on the proposed rules. Departments and agencies must then address “significant issues raised in comments and discuss any changes made,” the Federal Register says.

Notices published by the Justice Department on April 28

Title
Bulk Manufacturer of Controlled Substances Application: Research Triangle Institute
Importer of Controlled Substances Application: SpecGX LLC
Bulk Manufacturer of Controlled Substances Application: Sterling Wisconsin, LLC
Importer of Controlled Substances Application: Purisys, LLC
Importer of Controlled Substances Application: Lipomed
Importer of Controlled Substances Application: Royal Emerald Pharmaceuticals Research and Development
Importer of Controlled Substances Application: VHG Labs DBA LGC Standards
Bulk Manufacturer of Controlled Substances Application: SpecGx LLC

More News